Acute Myelogenous Leukemia Clinical Trials in Georgia

Cancer Type = Acute Myelogenous Leukemia

Cancer Type = Acute Myelogenous Leukemia

There are currently 5 active Acute Myelogenous Leukemia clinical trials in Georgia.
1.
A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Cancer Type
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Leukemia, Lymphoma, Neuroblastoma
NCI ID
NCT03236857
Protocol IDs
M13-833
NCI-2017-02027
2017-000439-14
2.
Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Cancer Type
Acute Myelogenous Leukemia
NCI ID
NCT01688011
Protocol IDs
4.
Matched Targeted Therapy (MTT) Recommendation for Patients with Recurrent, Refractory, or High Risk Leukemias
Cancer Type
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Leukemia, Lymphoma, Myelodysplastic Syndromes (MDS)
NCI ID
NCT02670525
Protocol IDs
15-384
NCI-2016-00336
5.
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Cancer Type
Acute Myelogenous Leukemia
NCI ID
NCT02521493
Protocol IDs
AAML1531
NCI-2015-00324
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.